Subcutaneous trastuzumab (Herceptin) injection shows promise.
D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007390:International Agencies; D015337:Multicenter Studies as Topic; D020360:Neoadjuvant Therapy; D012074:Remission Induction; D000068878:Trastuzumab
D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab